Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Clinical Trials in Oklahoma City, Oklahoma

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132